Searched for
EVEROLIMUS
Mark Cuban’s ‘beyond incredible’ gesture wins hearts after heart transplant survivor faces $1,000 bill for vital medicineAfter undergoing a heart transplant, a survivor encountered steep increases in medication costs, initially losing her insurance coverage on...- Biocon arm gets USFDA nod for generic Everolimus tabletsBiocon's arm, Biocon Pharma Ltd, has secured USFDA approval for its generic Everolimus tablets. This medication aids in treating tuberous s...
- Biocon plans $150-million capex in two yearsBiocon plans a $150 million capital expenditure, allocating $100 million to biologics, primarily enhancing Malaysian capacities, and $50 mi...
- Biocon Q3 Results: Net profit rises 11% YoY to Rs 187 croreThe earnings before interest, tax depreciation and amortisation (EBITDA) rose 25% YoY to Rs 537 crore. The EBITDA margins for the third qua...
- Stocks in the news: RIL, DMart, ZEEL, Federal Bank, NTPC and BSEReliance Industries has incorporated a new subsidiary in the UAE for trading in crude oil, petroleum products and agricultural commodities.
- Natco Pharma gets American drug regulator's nod for generic cancer treatment drugNatco, along with its marketing partner Arrow International previously settled the Paragraph IV litigation related to the product with Celg...
- Natco's marketing partner gets USFDA nod for cancer treatment drug"Breckenridge Pharmaceutical Inc (BPI) has received final approval for its abbreviated new drug application (ANDA) for Everolimus tablets f...
- It’s official, Indian-made stents as good as the bestA study presented two months back had also concluded that another Indian stent, Supra Flex was as good as Xience.
- Indian study on treating diabetics with heart ailments gets global recognitionAs per the findings, the use of Everolimus eluting stents may be equally or more useful in treating coronary blockages in diabetic patients...
- Does a real anti-ageing pill exist?Derivatives of rapamycin have been approved for use against certain kidney, lung and breast cancers.
- Natco pharma's US partner files Abbreviated New Drug Application for EverolimusThe drug, used to prevent organ rejection after a kidney or liver transplant, generated sales of $43.5 mn for the 12-mth period ending July.
- Pharmaceutical companies such as Cipla, Sun Pharma deny wrongdoing in introducing new drugsCipla said as per the law, it is not mandatory to carry out Phase III trials in India for each and every new drug.
Load More
